Press release
Viral Hepatitis Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers
Viral Hepatitis Market
The burgeoning incidence of hepatitis is predicted to fuel the expansion of the viral hepatitis market. Hepatitis, a liver infection caused by various infectious and non-infectious elements, can induce numerous health complications. Viral hepatitis, in particular, resulting from Hepatitis A, B, C, D, and E causes inflammation and damage to the liver. For instance, the European Centre for Disease Prevention and Control reported in April 2024 that there were 28,855 documented instances of hepatitis B virus (HBV) infection across 30 EU/EEA Member States in 2022, a 78% rise compared to 16,187 cases in 2021. The cases in 2022, which totaled to 28,420, indicates a crude rate of 8.5 cases per 100,000 individuals. Therefore, the growing incidence of hepatitis is likely to boost the viral hepatitis market. Market Driver for Viral Hepatitis: Augmentation in Research and Development Activities Propels Viral Hepatitis Market Growth
Get Your Viral Hepatitis Market Report Here:
https://www.thebusinessresearchcompany.com/report/viral-hepatitis-global-market-report
What is the projected compound annual growth rate (CAGR) of the viral hepatitis market from 2025 to 2034, and what factors influence it?
The market size for viral hepatitis has experienced consistent growth over the recent years. A rise from $16.21 billion in 2024 to $16.93 billion in 2025 is predicted, exhibiting a compound annual growth rate (CAGR) of 4.4%. Factors contributing to the growth during the historic period are the creation of vaccines, blood screening initiatives, antiviral medications, and international health campaigns.
The market size of viral hepatitis is anticipated to progressively grow in the forthcoming years. A compound annual growth rate (CAGR) of 4.2% will take it to a $19.97 billion valuation by 2029. The growth during the predicted period can be credited to factors such as the availability of treatment, public health laws, combination therapies, and initiatives focused on health equity. Noteworthy trends to be observed in this period comprise personalized treatment strategies, digital healthcare resources, applications of AI in monitoring diseases, along with micro-elimination of Hepatitis C.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13028&type=smp
How are the latest trends influencing the growth of the viral hepatitis market?
In an effort to maintain their position within the viral hepatitis market, businesses are focusing on the development and advancement of new drugs. Such innovation and development enhance scientific knowledge by providing a deeper understanding of disease mechanisms and fast-tracking the creation of new treatments. For example, Gilead Sciences Inc., a biopharmaceutical corporation based in the US, declared in November 2022 that the FDA had given its supplemental new medicine application (sNDA) for Vemlidy (tenofovir alafenamide) 25 mg tablets. This treatment, meant to be taken once a day, has been approved for the treatment of chronic hepatitis B virus (HBV) infection in children twelve years old and older suffering from compensated liver disease. The endorsement of Vemlidy for this group of pediatric patients was supported by results from a 24-week phase 2 clinical trial.
What are the major segments of the viral hepatitis market and their role in driving growth?
The viral hepatitis market covered in this report is segmented -
1) By Disease Type: Hepatitis A, Hepatitis B, Hepatitis C, Other Disease Types
2) By Diagnosis: Liver Biopsy, Blood Tests, Imaging Tests, Other Diagnosis
3) By Treatment: Antiviral Drugs, Surgery, Vaccine, Immune Modulator Drugs, Other Treatments
4) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users
Subsegments:
1) By Hepatitis A: Acute Hepatitis A, Chronic Hepatitis A
2) By Hepatitis B: Acute Hepatitis B, Chronic Hepatitis B, Hepatitis B Carrier
3) By Hepatitis C: Acute Hepatitis C, Chronic Hepatitis C
4) By Other Disease Types: Hepatitis D, Hepatitis E
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13028
North America was the largest region in the viral hepatitis market in 2024. The regions covered in viral hepatitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Who are the key firms paving the way for growth in the viral hepatitis market?
Major companies operating in the viral hepatitis market are Pfizer Inc., Johnson & Johnson Co, F Hoffmann-La Roche AG, Merck & Co., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb, Astra Zeneca Pharmaceuticals LP, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Co. Ltd., Hetero Drugs Ltd., Eisai Co. Ltd., Boehringer Ingelheim Group, Sun Pharmaceutical Industries Ltd., Lupin Limited, Dr. Reddy's Laboratories, Zydus Lifescience Ltd., Glenmark Pharmaceuticals Ltd., Cipla Ltd., Torrent Pharmaceuticals Ltd., Otsuka Pharmaceutical Co. Ltd., Wockhardt Ltd.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=13028&type=smp
What Is Covered In The Viral Hepatitis Global Market Report?
•Market Size Forecast: Examine the viral hepatitis market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the viral hepatitis market for a structured understanding.
•Key Players Overview: Analyze major players in the viral hepatitis market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the viral hepatitis market.
•Segment Contributions: Evaluate how different segments drive overall growth in the viral hepatitis market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the viral hepatitis market.
•Industry Challenges: Identify potential risks and obstacles affecting the viral hepatitis market.
•Competitive Landscape: Review strategic developments in the viral hepatitis market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Viral Hepatitis Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers here
News-ID: 3920015 • Views: …
More Releases from The Business Research Company
Diabetic Neuropathy Industry Report 2025-2034: Market Dynamics, Trends, And Fore …
The Diabetic Neuropathy Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Diabetic Neuropathy Market Size During the Forecast Period?
The market scale for diabetic neuropathy has seen a significant expansion in the past few years. Its growth is projected to rise from…
Evolving Market Trends In The Dental Restorative And Regenerative Material Indus …
The Dental Restorative And Regenerative Material Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Dental Restorative And Regenerative Material Market Size During the Forecast Period?
The market size for dental restorative and regenerative material has seen substantial growth in the recent past.…
Surge In Data Traffic Drives The Data Center Server Market: Key Factor Driving T …
The Data Center Server Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Data Center Server Market Size During the Forecast Period?
The size of the data center server market has consistently expanded over the recent years. The market is projected to increase…
Cryocooler Industry Report 2025-2034: Market Dynamics, Trends, And Forecasts
The Cryocooler Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Cryocooler Market Size During the Forecast Period?
The market size of cryocoolers has seen significant growth in the past few years. It is expected to increase from $3 billion in 2024 to…
More Releases for Hepatitis
Is Hepatitis A Vaccine Required?
Hepatitis A Vaccine Market describes its growth, size, share, Forecast and trends to 2025
Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.
Two types of HAV vaccines are currently available internationally:
1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available…
Hepatitis Drugs Market Is Growing Due to Increasing R&D Investments on Hepatitis …
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market.
Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market
Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest…
Hepatitis B Therapeutics Market Is Driven by Rising Incidence of Hepatitis B In …
Hepatitis B is a life threatening liver infection caused by hepatitis B virus. Adults who get affected by hepatitis B virus for a short time and then get cured is known as acute hepatitis B. Infection that lasts for a long time is known as chronic hepatitis B. Vaccine is the most preferred choice of doctors and physicians to protect people from the disease. The vaccine prevents the infection and…
Hepatitis E Hyperendemicity to Drive Hepatitis E Diagnostic Tests Market Growth
Global Hepatitis E Diagnostic Tests Market: Snapshot
The growing incidence of hepatitis E, a liver disease caused by infection due to the virus hepatitis E virus (HEV), is a leading cause of morbidity and mortality worldwide. There is increasing prevalence of hepatitis E in resource-limited region, such as various countries of Asia Pacific. The people of these regions suffer with frequent water contamination and have limited access to sanitation and hygiene,…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Hepatitis C Drug Pipeline Analysis
“Hepatitis C Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Hepatitis C. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. Insight for each…
